Detalhe da pesquisa
1.
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm.
Int J Mol Sci
; 23(21)2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36361712
2.
High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in Cervical Carcinogenesis.
J Epidemiol
; 31(12): 615-620, 2021 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536377
3.
Clinicopathologic characteristics of early gastric cancer according to specific intragastric location.
BMC Gastroenterol
; 19(1): 24, 2019 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30736729
4.
Ultrasonic versus monopolar energy-based surgical devices in terms of surgical smoke and lateral thermal damage (ULMOST): a randomized controlled trial.
Surg Endosc
; 32(11): 4415-4421, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633043
5.
Negative prognostic effect of low nuclear GLI1 expression in glioblastomas.
J Neurooncol
; 133(1): 69-76, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28417299
6.
Expression Pattern of Smad4/GATA3 as a Predictor of Survival in Invasive Ductal Carcinoma of the Breast.
Pathobiology
; 84(3): 130-138, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28288473
7.
Decreased expression of p27 is associated with malignant transformation and extrathyroidal extension in papillary thyroid carcinoma.
Tumour Biol
; 37(3): 3359-64, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446458
8.
Prognostic value of ERBB4 expression in patients with triple negative breast cancer.
BMC Cancer
; 16: 138, 2016 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26907936
9.
Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Genes Chromosomes Cancer
; 54(6): 383-96, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25832818
10.
Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
Int J Cancer
; 137(1): 221-9, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25429856
11.
A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
Int J Cancer
; 136(8): 1976-84, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25537444
12.
HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
Int J Cancer
; 136(7): 1629-35, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25157953
13.
Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan.
BMC Cancer
; 15: 747, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486455
14.
CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer.
Ann Surg Oncol
; 21(4): 1099-106, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24306658
15.
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
Invest New Drugs
; 32(3): 535-41, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24468885
16.
Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay.
Ann Hematol
; 93(3): 437-47, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23975159
17.
Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.
Gynecol Oncol
; 135(1): 108-17, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25014541
18.
Identification of ROS1 rearrangement in gastric adenocarcinoma.
Cancer
; 119(9): 1627-35, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23400546
19.
MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas.
Mod Pathol
; 26(12): 1632-41, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23807774
20.
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients.
Invest New Drugs
; 31(6): 1580-6, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24013904